Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer
Clinical trial NCT03627728 · COMPLETED
Trial details
- NCT number
- NCT03627728
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-13
- Primary completion
- 2022-06-21
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.